These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31760780)

  • 1. Associations between Self-Reported Daily Affect Ratings and Sleep Duration during the First Two Weeks of Antidepressant Therapy.
    Huntley ED; Swanson LM; Kolenic GE; Bertram H; Mooney A; Dopp R; Arnedt JT
    Behav Sleep Med; 2021; 19(1):1-11. PubMed ID: 31760780
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Restricted Time in Bed on Antidepressant Treatment Response: A Randomized Controlled Trial.
    Arnedt JT; Swanson LM; Dopp RR; Bertram HS; Mooney AJ; Huntley ED; Hoffmann RF; Armitage R
    J Clin Psychiatry; 2016 Oct; 77(10):e1218-e1225. PubMed ID: 27529765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insomnia as a Moderator of Response to Time in Bed Restriction for Augmenting Antidepressant Treatment: A Preliminary Investigation.
    Swanson LM; Huntley ED; Bertram H; Mooney A; Dopp R; Hoffmann R; Armitage R; Arnedt JT
    Behav Sleep Med; 2018; 16(4):315-324. PubMed ID: 27494414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation.
    Swanson LM; Burgess HJ; Huntley ED; Bertram H; Mooney A; Zollars J; Dopp R; Hoffmann R; Armitage R; Todd Arnedt J
    Psychiatry Res; 2017 Jun; 252():262-269. PubMed ID: 28285255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing presurgery sleep reduces postsurgery pain and analgesic use following joint replacement: a feasibility study.
    Roehrs TA; Roth T
    Sleep Med; 2017 May; 33():109-113. PubMed ID: 28449888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
    Duncan WC; Selter J; Brutsche N; Sarasso S; Zarate CA
    J Affect Disord; 2013 Feb; 145(1):115-9. PubMed ID: 22871531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients.
    Chang HH; Chi MH; Lee IH; Tsai HC; Gean PW; Yang YK; Lu RB; Chen PS
    J Affect Disord; 2013 Sep; 150(2):295-9. PubMed ID: 23664565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrestorative sleep in healthy, young adults without insomnia: associations with executive functioning, fatigue, and pre-sleep arousal.
    Tinajero R; Williams PG; Cribbet MR; Rau HK; Bride DL; Suchy Y
    Sleep Health; 2018 Jun; 4(3):284-291. PubMed ID: 29776623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
    Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
    Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.
    Duncan WC; Slonena E; Hejazi NS; Brutsche N; Yu KC; Park L; Ballard ED; Zarate CA
    Biol Psychiatry; 2017 Sep; 82(5):361-369. PubMed ID: 28457485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of adjuvant omega-3-polyunsaturated fatty acids on depression, sleep, and emotion regulation among outpatients with major depressive disorders - Results from a double-blind, randomized and placebo-controlled clinical trial.
    Jahangard L; Sadeghi A; Ahmadpanah M; Holsboer-Trachsler E; Sadeghi Bahmani D; Haghighi M; Brand S
    J Psychiatr Res; 2018 Dec; 107():48-56. PubMed ID: 30317101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
    Szegedi A; Jansen WT; van Willigenburg AP; van der Meulen E; Stassen HH; Thase ME
    J Clin Psychiatry; 2009 Mar; 70(3):344-53. PubMed ID: 19254516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.
    Mohamed S; Johnson GR; Sevilimedu V; Rao SD; Hicks PB; Chen P; Lauro K; Jurjus G; Pilkinton P; Davis L; Wilcox JA; Iranmanesh A; Sapra M; Aslam M; Michalets J; Thase M; Zisook S;
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32603560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery.
    Banks S; Van Dongen HP; Maislin G; Dinges DF
    Sleep; 2010 Aug; 33(8):1013-26. PubMed ID: 20815182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sleep restriction on affective functioning in adolescents with attention-deficit/hyperactivity disorder.
    Becker SP; Tamm L; Epstein JN; Beebe DW
    J Child Psychol Psychiatry; 2020 Oct; 61(10):1160-1168. PubMed ID: 32157691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.